We are live on ! Find out more
PFE icon

Pfizer
PFE

2,675 hedge funds and large institutions have $137B invested in Pfizer in 2020 Q4 according to their latest regulatory filings, with 314 funds opening new positions, 669 increasing their positions, 1,691 reducing their positions, and 110 closing their positions.

New
Increased
Maintained
Reduced
Closed

185% more first-time investments, than exits

New positions opened: 314 | Existing positions closed: 110

18% more call options, than puts

Call options by funds: $2.58B | Put options by funds: $2.19B

7% more funds holding

Funds holding: 2,509 → 2,675 (+166)

3% less capital invested

Capital invested by funds: $140B → $137B (-$3.59B)

5.86% less ownership

Funds ownership: 72.65% → 66.79% (-5.9%)

38% less funds holding in top 10

Funds holding in top 10: 103 → 64 (-39)

60% less repeat investments, than reductions

Existing positions increased: 669 | Existing positions reduced: 1,691

Holders
2,675
Holders Change
+166
Holders Change %
+6.62%
% of All Funds
47.33%
Holding in Top 10
64
Holding in Top 10 Change
-39
Holding in Top 10 Change %
-37.86%
% of All Funds
1.13%
New
314
Increased
669
Reduced
1,691
Closed
110
Calls
$2.58B
Puts
$2.19B
Net Calls
+$399M
Net Calls Change
+$117M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$185M
2
Citadel Advisors
Citadel Advisors
Florida
+$171M
3
CS
Credit Suisse
Switzerland
+$148M
4
Bank of New York Mellon
Bank of New York Mellon
New York
+$141M
5
O
OrbiMed
New York
+$133M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.47B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.01B
3
State Street
State Street
Massachusetts
-$921M
4
Macquarie Group
Macquarie Group
Australia
-$694M
5
Bank of America
Bank of America
North Carolina
-$613M
Name Holding Trade Value Shares
Change 		Change in
Stake
ICP
1051
Ironvine Capital Partners
Nebraska
$2.76M -$149K -4,053 -5%
GIM
1052
Guardian Investment Management
California
$2.76M -$94.5K -2,575 -3%
WSC
1053
Wellington Shields & Co
New York
$2.75M -$181K -4,948 -6%
EI
1054
EDMP Inc
Florida
$2.75M -$201K -5,477 -7%
TAM
1055
Taurus Asset Management
New York
$2.74M -$1.89M -51,641 -41%
AWA
1056
ARS Wealth Advisors
Florida
$2.74M -$96.4K -2,628 -3%
IBOK
1057
Independence Bank of Kentucky
Kentucky
$2.74M -$274K -7,469 -9%
PCM
1058
Princeton Capital Management
New Jersey
$2.72M -$26K -708 -0.9%
CCG
1059
Cypress Capital Group
Florida
$2.72M -$63.8K -1,738 -2%
BG
1060
Bellevue Group
Switzerland
$2.72M -$146K -3,991 -5%
IAS
1061
IMA Advisory Services
Colorado
$2.72M -$223K -6,086 -8%
MSAM
1062
Moloney Securities Asset Management
Missouri
$2.72M -$206K -5,627 -7%
MIC
1063
Meridian Investment Counsel
California
$2.72M -$93.2K -2,542 -3%
NERM
1064
New England Research & Management
Illinois
$2.71M -$501K -13,654 -16%
HCM
1065
Hollencrest Capital Management
California
$2.7M -$105K -2,855 -4%
CIAS
1066
Capital Investment Advisory Services
North Carolina
$2.7M +$233K +6,355 +9%
SIMM
1067
Stillwater Investment Management (Minnesota)
Minnesota
$2.69M -$164K -4,474 -6%
RHDIC
1068
R.H. Dinel Investment Counsel
California
$2.69M +$2.11M +57,583 +373%
WAS
1069
Wesleyan Assurance Society
United Kingdom
$2.69M -$145K -3,942 -5%
VNA
1070
Valley National Advisers
Pennsylvania
$2.69M -$127K -3,470 -5%
NFG
1071
Next Financial Group
Texas
$2.68M -$621K -16,934 -19%
FVWA
1072
Foster Victor Wealth Advisors
South Carolina
$2.68M +$86.3K +2,354 +3%
AMIM
1073
Aull & Monroe Investment Management
Alabama
$2.66M +$646K +17,607 +32%
MSFP
1074
Mark Sheptoff Financial Planning
Connecticut
$2.66M +$92.3K +2,517 +4%
IB
1075
Intrust Bank
Kansas
$2.66M +$14.2K +387 +0.5%
41 42
43
44 45

PFE Hedge Fund Activity: Q4 2020 in Review

2,675 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2020, worth a combined $137B — down 2.6% from $140B a quarter earlier.

Buyers outnumbered sellers: 314 funds opened new PFE positions and 110 closed out — a net gain of 204 holders — while 669 added to existing stakes and 1,691 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $185M. The largest seller was BlackRock, cutting an estimated $1.47B.

  • 2,675 institutional investors held Pfizer (PFE) as of Q4 2020, up from 2,509 in Q3 2020.
  • Funds reported $137B of Pfizer stock for Q4 2020, down 2.6% quarter-over-quarter.
  • 314 funds opened new Pfizer positions in Q4 2020 and 110 closed out, a net change of +204 holders.
  • The largest Pfizer buyer in Q4 2020 was Morgan Stanley, an estimated $185M added.
  • The largest Pfizer seller in Q4 2020 was BlackRock, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2020.